| 0 |
GRIP STRENGTH |
120 |
0.5240 |
| 1 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY NEGATIVE |
1 |
0.5000 |
| 2 |
CATHETER CULTURE |
1 |
0.5000 |
| 3 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
268 |
0.4012 |
| 4 |
LUPUS VULGARIS |
469 |
0.3722 |
| 5 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
169 |
0.3012 |
| 6 |
SWOLLEN JOINT COUNT |
74 |
0.2960 |
| 7 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
537 |
0.2681 |
| 8 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
530 |
0.2555 |
| 9 |
SWOLLEN JOINT COUNT INCREASED |
814 |
0.2550 |
| 10 |
RHEUMATIC FEVER |
1112 |
0.2492 |
| 11 |
C-REACTIVE PROTEIN |
224 |
0.2416 |
| 12 |
DISLOCATION OF VERTEBRA |
516 |
0.2260 |
| 13 |
FACET JOINT SYNDROME |
730 |
0.2240 |
| 14 |
X-RAY ABNORMAL |
397 |
0.2218 |
| 15 |
HEPATIC ENZYME |
32 |
0.2148 |
| 16 |
ACQUIRED PORPHYRIA |
14 |
0.1972 |
| 17 |
RETINITIS |
327 |
0.1891 |
| 18 |
DUODENAL ULCER PERFORATION |
1364 |
0.1832 |
| 19 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1206 |
0.1682 |
| 20 |
RHEUMATOID FACTOR POSITIVE |
963 |
0.1666 |
| 21 |
MUSCLE INJURY |
1261 |
0.1520 |
| 22 |
PORPHYRIA ACUTE |
214 |
0.1491 |
| 23 |
HELICOBACTER INFECTION |
1468 |
0.1427 |
| 24 |
FOLLICULITIS |
1438 |
0.1370 |
| 25 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
881 |
0.1355 |
| 26 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE |
3 |
0.1304 |
| 27 |
PERIPHERAL VENOUS DISEASE |
518 |
0.1267 |
| 28 |
C-REACTIVE PROTEIN ABNORMAL |
773 |
0.1204 |
| 29 |
PEMPHIGUS |
1495 |
0.1195 |
| 30 |
HAND DEFORMITY |
1472 |
0.1121 |
| 31 |
BONE EROSION |
358 |
0.1011 |
| 32 |
CATHETER SITE PARAESTHESIA |
1 |
0.1000 |
| 33 |
LABOUR AUGMENTATION |
1 |
0.1000 |
| 34 |
SERONEGATIVE ARTHRITIS |
106 |
0.0925 |
| 35 |
BREAST CANCER STAGE III |
591 |
0.0912 |
| 36 |
PERICARDITIS |
1454 |
0.0865 |
| 37 |
LIP DRY |
728 |
0.0801 |
| 38 |
HYPERCHOLESTEROLAEMIA |
750 |
0.0776 |
| 39 |
SYNOVITIS |
1383 |
0.0766 |
| 40 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
8 |
0.0762 |
| 41 |
ONYCHOMADESIS |
316 |
0.0752 |
| 42 |
GRIP STRENGTH DECREASED |
662 |
0.0751 |
| 43 |
JOINT RANGE OF MOTION DECREASED |
1004 |
0.0748 |
| 44 |
IRRITABLE BOWEL SYNDROME |
1457 |
0.0679 |
| 45 |
GLOSSODYNIA |
1490 |
0.0665 |
| 46 |
ONYCHOMYCOSIS |
292 |
0.0665 |
| 47 |
WOUND INFECTION |
706 |
0.0644 |
| 48 |
ICTERUS INDEX INCREASED |
1 |
0.0625 |
| 49 |
HYPOCHOLESTEROLAEMIA |
21 |
0.0595 |
| 50 |
SPINAL FUSION FRACTURE |
1 |
0.0556 |
| 51 |
DRUG TOLERANCE DECREASED |
156 |
0.0555 |
| 52 |
SWOLLEN JOINT COUNT ABNORMAL |
1 |
0.0526 |
| 53 |
BURSITIS |
633 |
0.0521 |
| 54 |
AUTOIMMUNE DISORDER |
503 |
0.0516 |
| 55 |
WOUND |
1429 |
0.0511 |
| 56 |
GAIT APRAXIA |
2 |
0.0488 |
| 57 |
PUSTULAR PSORIASIS |
167 |
0.0486 |
| 58 |
FIBROMYALGIA |
1113 |
0.0457 |
| 59 |
WALKING AID USER |
301 |
0.0456 |
| 60 |
IMPAIRED HEALING |
1454 |
0.0442 |
| 61 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
164 |
0.0436 |
| 62 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1461 |
0.0411 |
| 63 |
LIVER INJURY |
998 |
0.0406 |
| 64 |
FINGER DEFORMITY |
195 |
0.0402 |
| 65 |
LIVE BIRTH |
322 |
0.0385 |
| 66 |
EXOSTOSIS |
349 |
0.0382 |
| 67 |
EYE INJURY |
115 |
0.0378 |
| 68 |
BLEPHAROSPASM |
238 |
0.0378 |
| 69 |
TYPE 2 DIABETES MELLITUS |
1267 |
0.0376 |
| 70 |
LUPUS-LIKE SYNDROME |
333 |
0.0367 |
| 71 |
TENDER JOINT COUNT |
3 |
0.0357 |
| 72 |
ULCER HAEMORRHAGE |
237 |
0.0350 |
| 73 |
RASH VESICULAR |
166 |
0.0343 |
| 74 |
OBESITY |
541 |
0.0339 |
| 75 |
PULMONARY FIBROSIS |
649 |
0.0338 |
| 76 |
SCIATICA |
539 |
0.0338 |
| 77 |
NAIL DISORDER |
291 |
0.0332 |
| 78 |
CARDIAC MONITORING ABNORMAL |
1 |
0.0323 |
| 79 |
OSMOLAR GAP INCREASED |
3 |
0.0297 |
| 80 |
CONTRAINDICATED PRODUCT ADMINISTERED |
900 |
0.0297 |
| 81 |
PSORIATIC ARTHROPATHY |
1201 |
0.0296 |
| 82 |
FOOT DEFORMITY |
307 |
0.0277 |
| 83 |
LOWER LIMB FRACTURE |
531 |
0.0276 |
| 84 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
305 |
0.0275 |
| 85 |
LOWER RESPIRATORY TRACT INFECTION |
1227 |
0.0270 |
| 86 |
PRESCRIBED OVERDOSE |
491 |
0.0253 |
| 87 |
JOINT DISLOCATION |
268 |
0.0253 |
| 88 |
HIP ARTHROPLASTY |
386 |
0.0252 |
| 89 |
BREAST CANCER STAGE II |
208 |
0.0250 |
| 90 |
PRODUCT LABEL CONFUSION |
143 |
0.0245 |
| 91 |
OVERLAP SYNDROME |
17 |
0.0243 |
| 92 |
SYNOVIAL FLUID ANALYSIS |
2 |
0.0230 |
| 93 |
GAIT INABILITY |
763 |
0.0228 |
| 94 |
BLISTER |
1274 |
0.0227 |
| 95 |
ARTHROPATHY |
1255 |
0.0226 |
| 96 |
INFUSION RELATED REACTION |
1457 |
0.0220 |
| 97 |
BLOOD CHOLESTEROL INCREASED |
1014 |
0.0217 |
| 98 |
ILL-DEFINED DISORDER |
1276 |
0.0210 |
| 99 |
HEPATIC ENZYME INCREASED |
1429 |
0.0209 |
| 100 |
STOMATITIS |
1258 |
0.0207 |
| 101 |
GENERAL SYMPTOM |
153 |
0.0204 |
| 102 |
CONGENITAL ANOMALY |
155 |
0.0200 |
| 103 |
TISSUE RUPTURE |
1 |
0.0200 |
| 104 |
BACK INJURY |
215 |
0.0198 |
| 105 |
PRESCRIBED UNDERDOSE |
390 |
0.0195 |
| 106 |
NIGHT SWEATS |
617 |
0.0191 |
| 107 |
HEPATIC CIRRHOSIS |
359 |
0.0191 |
| 108 |
DISCOMFORT |
1164 |
0.0191 |
| 109 |
MYOSITIS |
171 |
0.0190 |
| 110 |
INJURY |
1335 |
0.0190 |
| 111 |
SPONDYLITIS |
69 |
0.0190 |
| 112 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
824 |
0.0184 |
| 113 |
WHEEZING |
1040 |
0.0175 |
| 114 |
OSTEOARTHRITIS |
735 |
0.0173 |
| 115 |
SLEEP DISORDER |
1212 |
0.0172 |
| 116 |
KNEE ARTHROPLASTY |
356 |
0.0169 |
| 117 |
COELIAC DISEASE |
163 |
0.0166 |
| 118 |
PERFORATION |
13 |
0.0161 |
| 119 |
ROAD TRAFFIC ACCIDENT |
666 |
0.0159 |
| 120 |
OEDEMA |
851 |
0.0157 |
| 121 |
MOBILITY DECREASED |
1109 |
0.0154 |
| 122 |
C-REACTIVE PROTEIN INCREASED |
561 |
0.0154 |
| 123 |
ANTIPHOSPHOLIPID ANTIBODIES |
3 |
0.0154 |
| 124 |
SLEEP DISORDER THERAPY |
3 |
0.0152 |
| 125 |
APPLICATION SITE CELLULITIS |
1 |
0.0149 |
| 126 |
DELIRIUM |
516 |
0.0149 |
| 127 |
SWELLING |
1385 |
0.0148 |
| 128 |
LIVER DISORDER |
649 |
0.0146 |
| 129 |
LIVER FUNCTION TEST INCREASED |
310 |
0.0144 |
| 130 |
SPINAL FUSION SURGERY |
57 |
0.0140 |
| 131 |
INFLAMMATION |
705 |
0.0136 |
| 132 |
NORMAL NEWBORN |
74 |
0.0136 |
| 133 |
DISABILITY |
257 |
0.0130 |
| 134 |
LUNG DISORDER |
616 |
0.0126 |
| 135 |
ADVERSE REACTION |
165 |
0.0124 |
| 136 |
JOINT SWELLING |
1478 |
0.0122 |
| 137 |
RHEUMATOID ARTHRITIS |
1379 |
0.0121 |
| 138 |
GASTROINTESTINAL DISORDER |
1060 |
0.0118 |
| 139 |
MUSCULOSKELETAL PAIN |
598 |
0.0114 |
| 140 |
JOINT STIFFNESS |
296 |
0.0113 |
| 141 |
EAR INFECTION |
300 |
0.0113 |
| 142 |
MUSCULOSKELETAL STIFFNESS |
985 |
0.0112 |
| 143 |
TASTE DISORDER |
225 |
0.0111 |
| 144 |
SYNOVIAL DISORDER |
5 |
0.0110 |
| 145 |
DRUG-INDUCED LIVER INJURY |
343 |
0.0109 |
| 146 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1256 |
0.0108 |
| 147 |
SINUSITIS |
1109 |
0.0108 |
| 148 |
PREGNANCY |
216 |
0.0108 |
| 149 |
CONTUSION |
1035 |
0.0107 |
| 150 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
175 |
0.0103 |
| 151 |
BACK DISORDER |
165 |
0.0101 |
| 152 |
INFUSION SITE REACTION |
30 |
0.0100 |
| 153 |
DRUG INTOLERANCE |
964 |
0.0100 |
| 154 |
MATERNAL EXPOSURE DURING PREGNANCY |
849 |
0.0095 |
| 155 |
ANALGESIC THERAPY |
3 |
0.0093 |
| 156 |
HYPERTROPHIC SCAR |
1 |
0.0092 |
| 157 |
TREATMENT FAILURE |
756 |
0.0091 |
| 158 |
DRY MOUTH |
736 |
0.0091 |
| 159 |
BRACHIAL PLEXOPATHY |
2 |
0.0090 |
| 160 |
TENOSYNOVITIS STENOSANS |
5 |
0.0090 |
| 161 |
DRUG THERAPY |
3 |
0.0088 |
| 162 |
BLOODY DISCHARGE |
10 |
0.0087 |
| 163 |
THERAPY NON-RESPONDER |
390 |
0.0087 |
| 164 |
INFECTION |
1239 |
0.0086 |
| 165 |
CONFUSIONAL STATE |
1367 |
0.0084 |
| 166 |
DYSPEPSIA |
810 |
0.0082 |
| 167 |
EPILEPSY |
251 |
0.0082 |
| 168 |
INTENTIONAL PRODUCT USE ISSUE |
719 |
0.0082 |
| 169 |
WEIGHT FLUCTUATION |
85 |
0.0081 |
| 170 |
AMNESIA |
519 |
0.0080 |
| 171 |
FREQUENT BOWEL MOVEMENTS |
213 |
0.0079 |
| 172 |
APPENDICOLITH |
3 |
0.0078 |
| 173 |
HYPERSENSITIVITY |
1429 |
0.0077 |
| 174 |
ABDOMINAL DISCOMFORT |
1290 |
0.0077 |
| 175 |
PERIPHERAL SWELLING |
1183 |
0.0077 |
| 176 |
OSTEOPOROSIS |
314 |
0.0076 |
| 177 |
ILIAC ARTERY STENOSIS |
1 |
0.0076 |
| 178 |
MIGRAINE |
697 |
0.0073 |
| 179 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
124 |
0.0072 |
| 180 |
MYCETOMA MYCOTIC |
1 |
0.0072 |
| 181 |
GASTROINTESTINAL STOMA OUTPUT DECREASED |
1 |
0.0071 |
| 182 |
JOINT DESTRUCTION |
11 |
0.0071 |
| 183 |
HYPOAESTHESIA |
1043 |
0.0070 |
| 184 |
NASOPHARYNGITIS |
1284 |
0.0070 |
| 185 |
HEPATITIS |
177 |
0.0069 |
| 186 |
ALOPECIA |
1324 |
0.0067 |
| 187 |
URTICARIA |
1108 |
0.0066 |
| 188 |
NEUROSYPHILIS |
1 |
0.0066 |
| 189 |
MEDICATION ERROR |
346 |
0.0062 |
| 190 |
EXPOSURE DURING PREGNANCY |
380 |
0.0061 |
| 191 |
WEIGHT INCREASED |
1287 |
0.0057 |
| 192 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
268 |
0.0056 |
| 193 |
HYPERTENSION |
1172 |
0.0055 |
| 194 |
MEMORY IMPAIRMENT |
737 |
0.0054 |
| 195 |
SPONDYLOLYSIS |
1 |
0.0053 |
| 196 |
HYPERTRANSAMINASAEMIA |
37 |
0.0053 |
| 197 |
DEAFNESS PERMANENT |
1 |
0.0051 |
| 198 |
DEATH NEONATAL |
7 |
0.0050 |
| 199 |
RECTAL HAEMORRHAGE |
215 |
0.0050 |
| 200 |
ASTHMA |
565 |
0.0050 |
| 201 |
COLITIS ULCERATIVE |
222 |
0.0050 |
| 202 |
STARVATION KETOACIDOSIS |
1 |
0.0050 |
| 203 |
RESPIRATORY DISORDER |
148 |
0.0049 |
| 204 |
LABORATORY TEST ABNORMAL |
144 |
0.0049 |
| 205 |
NAIL OPERATION |
2 |
0.0048 |
| 206 |
INTERNATIONAL NORMALISED RATIO FLUCTUATION |
10 |
0.0048 |
| 207 |
ADVERSE EVENT |
430 |
0.0047 |
| 208 |
OSTEORADIONECROSIS |
1 |
0.0045 |
| 209 |
OEDEMA PERIPHERAL |
537 |
0.0044 |
| 210 |
EAR PAIN |
85 |
0.0044 |
| 211 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
298 |
0.0042 |
| 212 |
MUSCLE SPASTICITY |
51 |
0.0041 |
| 213 |
WHITE BLOOD CELL COUNT INCREASED |
159 |
0.0041 |
| 214 |
ABDOMINAL PAIN UPPER |
852 |
0.0041 |
| 215 |
BREAST CANCER STAGE I |
38 |
0.0041 |
| 216 |
MUSCULAR WEAKNESS |
458 |
0.0040 |
| 217 |
ARTHRITIS |
314 |
0.0040 |
| 218 |
CHEST PAIN |
737 |
0.0040 |
| 219 |
INSOMNIA |
1052 |
0.0039 |
| 220 |
VIBRATORY SENSE INCREASED |
1 |
0.0039 |
| 221 |
STEROID WITHDRAWAL SYNDROME |
4 |
0.0039 |
| 222 |
UPPER RESPIRATORY TRACT INFECTION |
179 |
0.0039 |
| 223 |
RED BLOOD CELL SEDIMENTATION RATE DECREASED |
1 |
0.0038 |
| 224 |
EXTRADURAL ABSCESS |
3 |
0.0038 |
| 225 |
CONDITION AGGRAVATED |
1146 |
0.0038 |
| 226 |
INJECTION SITE REACTION |
253 |
0.0037 |
| 227 |
DAIRY INTOLERANCE |
1 |
0.0036 |
| 228 |
PANCREATITIS |
187 |
0.0035 |
| 229 |
NECK PAIN |
197 |
0.0035 |
| 230 |
FLUID RETENTION |
178 |
0.0035 |
| 231 |
PARAESTHESIA |
534 |
0.0034 |
| 232 |
MUSCLE SPASMS |
618 |
0.0034 |
| 233 |
PRODUCT USE ISSUE |
625 |
0.0033 |
| 234 |
DECREASED APPETITE |
769 |
0.0033 |
| 235 |
RASH |
1440 |
0.0033 |
| 236 |
FEELING HOT |
202 |
0.0033 |
| 237 |
RESPIRATORY FUME INHALATION DISORDER |
1 |
0.0032 |
| 238 |
PYREXIA |
1116 |
0.0032 |
| 239 |
ALLERGY TO CHEMICALS |
4 |
0.0032 |
| 240 |
GAIT DISTURBANCE |
607 |
0.0032 |
| 241 |
SCLERITIS |
5 |
0.0031 |
| 242 |
GASTROOESOPHAGEAL REFLUX DISEASE |
250 |
0.0031 |
| 243 |
ADVERSE DRUG REACTION |
275 |
0.0031 |
| 244 |
DEPRESSION |
692 |
0.0030 |
| 245 |
PRURITUS |
1168 |
0.0030 |
| 246 |
LYME DISEASE |
10 |
0.0030 |
| 247 |
ALCOHOL POISONING |
8 |
0.0030 |
| 248 |
ARTHRALGIA |
1220 |
0.0029 |
| 249 |
PAIN IN EXTREMITY |
852 |
0.0029 |
| 250 |
PRODUCT USE IN UNAPPROVED INDICATION |
705 |
0.0028 |
| 251 |
TRYPTASE INCREASED |
2 |
0.0028 |
| 252 |
JOINT ARTHROPLASTY |
5 |
0.0028 |
| 253 |
THERAPEUTIC RESPONSE DECREASED |
167 |
0.0028 |
| 254 |
UNDERDOSE |
199 |
0.0027 |
| 255 |
VISUAL IMPAIRMENT |
328 |
0.0026 |
| 256 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
4 |
0.0026 |
| 257 |
DRUG TOLERANCE |
13 |
0.0026 |
| 258 |
PRODUCT CONTAMINATION MICROBIAL |
3 |
0.0025 |
| 259 |
PNEUMONIA |
806 |
0.0025 |
| 260 |
DENTAL FISTULA |
1 |
0.0024 |
| 261 |
PAIN |
1431 |
0.0023 |
| 262 |
DIABETIC HYPEROSMOLAR COMA |
1 |
0.0023 |
| 263 |
PSORIASIS |
299 |
0.0023 |
| 264 |
BODY TEMPERATURE INCREASED |
46 |
0.0023 |
| 265 |
DYSPNOEA |
1266 |
0.0022 |
| 266 |
HEPATIC ENZYME DECREASED |
1 |
0.0022 |
| 267 |
IRON DEFICIENCY |
10 |
0.0022 |
| 268 |
GENERAL ANAESTHESIA |
1 |
0.0022 |
| 269 |
VOMITING |
1037 |
0.0022 |
| 270 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
5 |
0.0022 |
| 271 |
METAPLASIA |
1 |
0.0021 |
| 272 |
BLOOD CHOLESTEROL |
1 |
0.0021 |
| 273 |
OCULAR NEOPLASM |
1 |
0.0021 |
| 274 |
ABDOMINAL DISTENSION |
219 |
0.0021 |
| 275 |
MALAISE |
885 |
0.0020 |
| 276 |
BRONCHITIS |
148 |
0.0020 |
| 277 |
WEIGHT DECREASED |
541 |
0.0019 |
| 278 |
TACHYCARDIA |
171 |
0.0019 |
| 279 |
POLYARTHRITIS |
10 |
0.0019 |
| 280 |
GASTRIC ANTRAL VASCULAR ECTASIA |
1 |
0.0019 |
| 281 |
CUSHINGOID |
6 |
0.0019 |
| 282 |
ANXIETY |
529 |
0.0019 |
| 283 |
DUODENAL ULCER |
13 |
0.0018 |
| 284 |
RHEUMATOID NODULE |
5 |
0.0018 |
| 285 |
PLEURITIC PAIN |
5 |
0.0018 |
| 286 |
APNOEIC ATTACK |
1 |
0.0018 |
| 287 |
FATIGUE |
1380 |
0.0018 |
| 288 |
RASH PRURITIC |
96 |
0.0018 |
| 289 |
ABDOMINAL PAIN |
405 |
0.0017 |
| 290 |
PALMAR ERYTHEMA |
2 |
0.0017 |
| 291 |
CHEMICAL BURN |
2 |
0.0017 |
| 292 |
CREPITATIONS |
5 |
0.0017 |
| 293 |
DIAPHRAGMATIC PARALYSIS |
1 |
0.0017 |
| 294 |
BRAIN DEATH |
5 |
0.0016 |
| 295 |
HEADACHE |
1012 |
0.0016 |
| 296 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
2 |
0.0016 |
| 297 |
PRODUCT QUALITY ISSUE |
218 |
0.0016 |
| 298 |
DIZZINESS |
795 |
0.0016 |
| 299 |
INTERVERTEBRAL DISCITIS |
3 |
0.0016 |
| 300 |
FOETAL EXPOSURE DURING PREGNANCY |
129 |
0.0016 |
| 301 |
BACILLUS INFECTION |
1 |
0.0016 |
| 302 |
ASTHENIA |
588 |
0.0016 |
| 303 |
NEUROPATHIC ARTHROPATHY |
1 |
0.0015 |
| 304 |
ANTINUCLEAR ANTIBODY POSITIVE |
5 |
0.0015 |
| 305 |
POSTOPERATIVE ADHESION |
1 |
0.0015 |
| 306 |
PROTEIN TOTAL INCREASED |
4 |
0.0015 |
| 307 |
DIARRHOEA |
920 |
0.0014 |
| 308 |
HYPERPHOSPHATAEMIA |
3 |
0.0014 |
| 309 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
1 |
0.0014 |
| 310 |
OFF LABEL USE |
1177 |
0.0013 |
| 311 |
ARTERIAL INJURY |
1 |
0.0013 |
| 312 |
NAUSEA |
1053 |
0.0013 |
| 313 |
PREGNANCY AFTER POST COITAL CONTRACEPTION |
3 |
0.0013 |
| 314 |
HOSPITALISATION |
192 |
0.0012 |
| 315 |
CHEMICAL INJURY |
1 |
0.0012 |
| 316 |
LEUKOPENIA |
61 |
0.0012 |
| 317 |
CARDIAC STRESS TEST ABNORMAL |
1 |
0.0012 |
| 318 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
4 |
0.0012 |
| 319 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
25 |
0.0012 |
| 320 |
THROMBOCYTOPENIA |
125 |
0.0011 |
| 321 |
PRIMARY SEQUESTRUM |
1 |
0.0011 |
| 322 |
BLOOD PHOSPHORUS INCREASED |
3 |
0.0011 |
| 323 |
SYNOVIAL CYST |
5 |
0.0011 |
| 324 |
ULCER |
17 |
0.0011 |
| 325 |
BUNDLE BRANCH BLOCK |
1 |
0.0011 |
| 326 |
HEPATIC NECROSIS |
4 |
0.0011 |
| 327 |
SACROILIITIS |
2 |
0.0011 |
| 328 |
WOUND SECRETION |
4 |
0.0010 |
| 329 |
MASTOIDITIS |
1 |
0.0010 |
| 330 |
DUODENAL PERFORATION |
1 |
0.0010 |
| 331 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 332 |
ABSCESS JAW |
1 |
0.0010 |
| 333 |
RESPIRATORY TRACT INFECTION |
25 |
0.0010 |
| 334 |
SPINAL DISORDER |
9 |
0.0009 |
| 335 |
SINUSITIS BACTERIAL |
1 |
0.0009 |
| 336 |
BURNS THIRD DEGREE |
1 |
0.0009 |
| 337 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 338 |
VASCULAR CALCIFICATION |
1 |
0.0009 |
| 339 |
ASPIRATION |
10 |
0.0009 |
| 340 |
ADRENAL INSUFFICIENCY |
11 |
0.0009 |
| 341 |
PERIRECTAL ABSCESS |
1 |
0.0009 |
| 342 |
HALO VISION |
1 |
0.0009 |
| 343 |
IMMUNODEFICIENCY |
13 |
0.0009 |
| 344 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 345 |
DYSPLASIA |
1 |
0.0008 |
| 346 |
DRUG INEFFECTIVE |
1090 |
0.0008 |
| 347 |
PRODUCT PACKAGING CONFUSION |
2 |
0.0008 |
| 348 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 349 |
EJECTION FRACTION ABNORMAL |
1 |
0.0008 |
| 350 |
SECRETION DISCHARGE |
10 |
0.0008 |
| 351 |
ADJUSTMENT DISORDER |
1 |
0.0008 |
| 352 |
PLATELET COUNT INCREASED |
10 |
0.0008 |
| 353 |
RESPIRATORY ACIDOSIS |
3 |
0.0008 |
| 354 |
AREFLEXIA |
2 |
0.0007 |
| 355 |
JOINT EFFUSION |
5 |
0.0007 |
| 356 |
TENOSYNOVITIS |
2 |
0.0007 |
| 357 |
SKIN ATROPHY |
4 |
0.0007 |
| 358 |
HYPERTHERMIA MALIGNANT |
1 |
0.0007 |
| 359 |
INFERTILITY |
1 |
0.0007 |
| 360 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 361 |
FALL |
211 |
0.0006 |
| 362 |
INTERMITTENT CLAUDICATION |
1 |
0.0006 |
| 363 |
SPINAL CORD DISORDER |
1 |
0.0006 |
| 364 |
SKIN WOUND |
1 |
0.0006 |
| 365 |
INTENTIONAL PRODUCT MISUSE |
51 |
0.0006 |
| 366 |
HYPOPNOEA |
2 |
0.0006 |
| 367 |
FORMICATION |
4 |
0.0006 |
| 368 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 369 |
TREATMENT NONCOMPLIANCE |
31 |
0.0006 |
| 370 |
LIVER TRANSPLANT REJECTION |
1 |
0.0006 |
| 371 |
NODULE |
7 |
0.0005 |
| 372 |
FLANK PAIN |
5 |
0.0005 |
| 373 |
OVERDOSE |
115 |
0.0005 |
| 374 |
GUN SHOT WOUND |
1 |
0.0005 |
| 375 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 376 |
BLOOD URIC ACID INCREASED |
3 |
0.0005 |
| 377 |
ATELECTASIS |
5 |
0.0005 |
| 378 |
SPINAL CORD COMPRESSION |
2 |
0.0005 |
| 379 |
EMPYEMA |
1 |
0.0005 |
| 380 |
OSTEOLYSIS |
1 |
0.0005 |
| 381 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 382 |
TENDERNESS |
5 |
0.0005 |
| 383 |
ATRIAL TACHYCARDIA |
1 |
0.0005 |
| 384 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 385 |
DEREALISATION |
1 |
0.0005 |
| 386 |
JAW FRACTURE |
1 |
0.0005 |
| 387 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 388 |
PSEUDOMEMBRANOUS COLITIS |
1 |
0.0004 |
| 389 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 390 |
WRONG PRODUCT ADMINISTERED |
3 |
0.0004 |
| 391 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 392 |
BREAKTHROUGH PAIN |
1 |
0.0004 |
| 393 |
THERMAL BURN |
3 |
0.0004 |
| 394 |
VOLVULUS |
1 |
0.0004 |
| 395 |
GASTROINTESTINAL TOXICITY |
2 |
0.0004 |
| 396 |
DERMAL CYST |
1 |
0.0004 |
| 397 |
APPLICATION SITE BURN |
2 |
0.0004 |
| 398 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 399 |
MULTIPLE DRUG OVERDOSE |
2 |
0.0004 |
| 400 |
EYELID IRRITATION |
1 |
0.0004 |
| 401 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 402 |
STAPHYLOCOCCAL INFECTION |
13 |
0.0004 |
| 403 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
2 |
0.0004 |
| 404 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 405 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 406 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 407 |
MYASTHENIA GRAVIS |
3 |
0.0004 |
| 408 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 409 |
MACULE |
1 |
0.0004 |
| 410 |
ACCIDENTAL OVERDOSE |
13 |
0.0004 |
| 411 |
VITAMIN B12 DECREASED |
1 |
0.0003 |
| 412 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 413 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 414 |
APPENDICITIS |
3 |
0.0003 |
| 415 |
NO ADVERSE EVENT |
58 |
0.0003 |
| 416 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 417 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 418 |
HEPATOTOXICITY |
7 |
0.0003 |
| 419 |
SUBSTANCE USE DISORDER |
1 |
0.0003 |
| 420 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 421 |
MULTIPLE DRUG OVERDOSE INTENTIONAL |
1 |
0.0003 |
| 422 |
HIGH DENSITY LIPOPROTEIN DECREASED |
1 |
0.0003 |
| 423 |
QUALITY OF LIFE DECREASED |
4 |
0.0003 |
| 424 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 425 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 426 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
2 |
0.0003 |
| 427 |
APPLICATION SITE REACTION |
2 |
0.0003 |
| 428 |
SKIN REACTION |
4 |
0.0003 |
| 429 |
PULMONARY TOXICITY |
2 |
0.0003 |
| 430 |
SINUS TACHYCARDIA |
4 |
0.0003 |
| 431 |
VENTRICULAR FIBRILLATION |
3 |
0.0003 |
| 432 |
CONJUNCTIVITIS |
5 |
0.0003 |
| 433 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 434 |
PHOTOPHOBIA |
5 |
0.0003 |
| 435 |
TROPONIN INCREASED |
2 |
0.0003 |
| 436 |
BACK PAIN |
61 |
0.0003 |
| 437 |
FEELING JITTERY |
5 |
0.0003 |
| 438 |
HYPOKALAEMIA |
12 |
0.0003 |
| 439 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 440 |
APNOEA |
2 |
0.0003 |
| 441 |
MUSCLE DISORDER |
2 |
0.0002 |
| 442 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 443 |
BRAIN OEDEMA |
3 |
0.0002 |
| 444 |
ABSCESS LIMB |
1 |
0.0002 |
| 445 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 446 |
IMPAIRED WORK ABILITY |
5 |
0.0002 |
| 447 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 448 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 449 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 450 |
CATHETERISATION CARDIAC |
1 |
0.0002 |
| 451 |
MENINGITIS ASEPTIC |
1 |
0.0002 |
| 452 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 453 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 454 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 455 |
RESPIRATORY DISTRESS |
6 |
0.0002 |
| 456 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 457 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 458 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 459 |
DEATH |
185 |
0.0002 |
| 460 |
ROSACEA |
1 |
0.0002 |
| 461 |
DEFORMITY |
2 |
0.0002 |
| 462 |
SUSPECTED SUICIDE |
1 |
0.0002 |
| 463 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
6 |
0.0002 |
| 464 |
CARDIOGENIC SHOCK |
3 |
0.0002 |
| 465 |
PARAESTHESIA ORAL |
3 |
0.0002 |
| 466 |
NEURALGIA |
5 |
0.0002 |
| 467 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 468 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 469 |
DIABETIC NEUROPATHY |
1 |
0.0002 |
| 470 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 471 |
HYPOTONIA |
2 |
0.0002 |
| 472 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 473 |
VAGINAL DISCHARGE |
2 |
0.0002 |
| 474 |
ENDOCARDITIS |
1 |
0.0002 |
| 475 |
UNRESPONSIVE TO STIMULI |
5 |
0.0002 |
| 476 |
SKIN ULCER |
5 |
0.0002 |
| 477 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 478 |
FOETAL DEATH |
1 |
0.0002 |
| 479 |
MALABSORPTION |
1 |
0.0002 |
| 480 |
APPLICATION SITE ERYTHEMA |
5 |
0.0002 |
| 481 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 482 |
DEPRESSED MOOD |
10 |
0.0002 |
| 483 |
METABOLIC ACIDOSIS |
6 |
0.0002 |
| 484 |
ANAL FISTULA |
1 |
0.0002 |
| 485 |
INTENTIONAL OVERDOSE |
12 |
0.0002 |
| 486 |
BRUXISM |
1 |
0.0002 |
| 487 |
MENTAL STATUS CHANGES |
5 |
0.0002 |
| 488 |
SKIN INFECTION |
2 |
0.0002 |
| 489 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 490 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 491 |
MUSCLE TWITCHING |
4 |
0.0002 |
| 492 |
RALES |
1 |
0.0002 |
| 493 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
31 |
0.0002 |
| 494 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 495 |
DECREASED INTEREST |
1 |
0.0002 |
| 496 |
ENERGY INCREASED |
1 |
0.0002 |
| 497 |
BACTERAEMIA |
2 |
0.0002 |
| 498 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 499 |
GANGRENE |
1 |
0.0002 |
| 500 |
RESPIRATORY DEPRESSION |
2 |
0.0002 |
| 501 |
DRUG ABUSER |
1 |
0.0002 |
| 502 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 503 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 504 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 505 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 506 |
FOREIGN BODY SENSATION IN EYES |
1 |
0.0002 |
| 507 |
PROCTALGIA |
1 |
0.0002 |
| 508 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 509 |
TENDON DISORDER |
1 |
0.0002 |
| 510 |
MENINGITIS |
1 |
0.0001 |
| 511 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 512 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 513 |
CROHN'S DISEASE |
1 |
0.0001 |
| 514 |
ECCHYMOSIS |
1 |
0.0001 |
| 515 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
8 |
0.0001 |
| 516 |
ONYCHOCLASIS |
1 |
0.0001 |
| 517 |
LYMPHOEDEMA |
1 |
0.0001 |
| 518 |
INTENTIONAL DRUG MISUSE |
3 |
0.0001 |
| 519 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 520 |
PAPULE |
1 |
0.0001 |
| 521 |
EYE PAIN |
8 |
0.0001 |
| 522 |
DIVERTICULUM |
1 |
0.0001 |
| 523 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 524 |
TOXICITY TO VARIOUS AGENTS |
23 |
0.0001 |
| 525 |
ASCITES |
4 |
0.0001 |
| 526 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 527 |
PEMPHIGOID |
1 |
0.0001 |
| 528 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 529 |
ACIDOSIS |
1 |
0.0001 |
| 530 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 531 |
HAEMOLYSIS |
1 |
0.0001 |
| 532 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 533 |
OCULAR HYPERAEMIA |
6 |
0.0001 |
| 534 |
RENAL CYST |
1 |
0.0001 |
| 535 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 536 |
HAEMORRHAGE |
13 |
0.0001 |
| 537 |
INTERSTITIAL LUNG DISEASE |
6 |
0.0001 |
| 538 |
SUBSTANCE ABUSE |
1 |
0.0001 |
| 539 |
DRY EYE |
6 |
0.0001 |
| 540 |
LOSS OF CONSCIOUSNESS |
15 |
0.0001 |
| 541 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 542 |
ANURIA |
1 |
0.0001 |
| 543 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 544 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 545 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 546 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 547 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 548 |
OSTEOMYELITIS |
2 |
0.0001 |
| 549 |
HYPOTENSION |
22 |
0.0001 |
| 550 |
HIDRADENITIS |
1 |
0.0001 |
| 551 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 552 |
DEEP VEIN THROMBOSIS |
7 |
0.0001 |
| 553 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 554 |
POISONING DELIBERATE |
1 |
0.0001 |
| 555 |
NEOPLASM MALIGNANT |
7 |
0.0001 |
| 556 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 557 |
EYE IRRITATION |
6 |
0.0001 |
| 558 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 559 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 560 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 561 |
BRAIN INJURY |
1 |
0.0001 |
| 562 |
THROMBOSIS |
8 |
0.0001 |
| 563 |
HYPOTHERMIA |
1 |
0.0001 |
| 564 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 565 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 566 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 567 |
BONE DENSITY DECREASED |
3 |
0.0001 |
| 568 |
JOINT INJURY |
2 |
0.0001 |
| 569 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 570 |
SKIN LACERATION |
1 |
0.0001 |
| 571 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 572 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 573 |
SCAB |
1 |
0.0001 |
| 574 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 575 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 576 |
PRESYNCOPE |
2 |
0.0001 |
| 577 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 578 |
CARDIOMEGALY |
1 |
0.0001 |
| 579 |
SEPSIS |
9 |
0.0001 |
| 580 |
CYST |
1 |
0.0001 |
| 581 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 582 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 583 |
SWELLING FACE |
5 |
0.0001 |
| 584 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 585 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 586 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 587 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 588 |
WHITE BLOOD CELL COUNT DECREASED |
8 |
0.0001 |
| 589 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 590 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 591 |
COMPLETED SUICIDE |
6 |
0.0001 |
| 592 |
MASS |
1 |
0.0001 |
| 593 |
HYPONATRAEMIA |
4 |
0.0001 |
| 594 |
LYMPHOPENIA |
1 |
0.0001 |
| 595 |
PARALYSIS |
1 |
0.0001 |
| 596 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 597 |
LETHARGY |
4 |
0.0001 |
| 598 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 599 |
PULMONARY MASS |
1 |
0.0001 |
| 600 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 601 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 602 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 603 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 604 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 605 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 606 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 607 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 608 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 609 |
METASTASES TO BONE |
1 |
0.0001 |
| 610 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 611 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 612 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 613 |
LIP SWELLING |
2 |
0.0001 |
| 614 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 615 |
SKIN EXFOLIATION |
5 |
0.0001 |
| 616 |
GASTRIC DISORDER |
2 |
0.0001 |
| 617 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 618 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 619 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 620 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 621 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 622 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 623 |
BONE DISORDER |
1 |
0.0001 |
| 624 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 625 |
AGITATION |
4 |
0.0001 |
| 626 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 627 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 628 |
FOOT FRACTURE |
1 |
0.0001 |
| 629 |
GASTRIC ULCER |
1 |
0.0001 |
| 630 |
DIABETES MELLITUS |
4 |
0.0001 |
| 631 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 632 |
PRODUCT SUBSTITUTION ISSUE |
3 |
0.0001 |
| 633 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 634 |
HERNIA |
1 |
0.0001 |
| 635 |
DYSPHONIA |
3 |
0.0001 |
| 636 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 637 |
KIDNEY INFECTION |
1 |
0.0001 |
| 638 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 639 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 640 |
SPINAL FRACTURE |
1 |
0.0000 |
| 641 |
RIB FRACTURE |
1 |
0.0000 |
| 642 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 643 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 644 |
SEPTIC SHOCK |
2 |
0.0000 |
| 645 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 646 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 647 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 648 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 649 |
SOMNOLENCE |
9 |
0.0000 |
| 650 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 651 |
SEIZURE |
5 |
0.0000 |
| 652 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 653 |
PALPITATIONS |
5 |
0.0000 |
| 654 |
COMA |
2 |
0.0000 |
| 655 |
LOCALISED INFECTION |
1 |
0.0000 |
| 656 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 657 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 658 |
HEART RATE INCREASED |
4 |
0.0000 |
| 659 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 660 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 661 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 662 |
HAEMATEMESIS |
1 |
0.0000 |
| 663 |
DIPLOPIA |
1 |
0.0000 |
| 664 |
GASTRITIS |
1 |
0.0000 |
| 665 |
FEAR |
1 |
0.0000 |
| 666 |
PALLOR |
1 |
0.0000 |
| 667 |
DRUG ABUSE |
3 |
0.0000 |
| 668 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 669 |
PAIN IN JAW |
1 |
0.0000 |
| 670 |
MYALGIA |
6 |
0.0000 |
| 671 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 672 |
ERYTHEMA |
7 |
0.0000 |
| 673 |
RENAL INJURY |
1 |
0.0000 |
| 674 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 675 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 676 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 677 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 678 |
CYSTITIS |
1 |
0.0000 |
| 679 |
MOOD SWINGS |
1 |
0.0000 |
| 680 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 681 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 682 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 683 |
RENAL FAILURE |
4 |
0.0000 |
| 684 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 685 |
FEELING ABNORMAL |
7 |
0.0000 |
| 686 |
BURNING SENSATION |
2 |
0.0000 |
| 687 |
HYPERKALAEMIA |
1 |
0.0000 |
| 688 |
HEART RATE DECREASED |
1 |
0.0000 |
| 689 |
HYPOXIA |
1 |
0.0000 |
| 690 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 691 |
DYSURIA |
1 |
0.0000 |
| 692 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 693 |
COLITIS |
1 |
0.0000 |
| 694 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 695 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 696 |
DISORIENTATION |
1 |
0.0000 |
| 697 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 698 |
CARDIAC ARREST |
2 |
0.0000 |
| 699 |
POLLAKIURIA |
1 |
0.0000 |
| 700 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 701 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 702 |
CONSTIPATION |
5 |
0.0000 |
| 703 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 704 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 705 |
TINNITUS |
1 |
0.0000 |
| 706 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 707 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 708 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 709 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 710 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 711 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 712 |
CELLULITIS |
1 |
0.0000 |
| 713 |
THERAPY CESSATION |
1 |
0.0000 |
| 714 |
NERVOUSNESS |
1 |
0.0000 |
| 715 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 716 |
HERPES ZOSTER |
1 |
0.0000 |
| 717 |
SURGERY |
1 |
0.0000 |
| 718 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 719 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 720 |
ANAEMIA |
3 |
0.0000 |
| 721 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 722 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 723 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 724 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 725 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 726 |
DYSGEUSIA |
1 |
0.0000 |
| 727 |
HALLUCINATION |
1 |
0.0000 |
| 728 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 729 |
ACNE |
1 |
0.0000 |
| 730 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 731 |
TREMOR |
2 |
0.0000 |
| 732 |
BALANCE DISORDER |
1 |
0.0000 |
| 733 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 734 |
CARDIAC DISORDER |
1 |
0.0000 |
| 735 |
DYSPHAGIA |
1 |
0.0000 |
| 736 |
SYNCOPE |
1 |
0.0000 |
| 737 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 738 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 739 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 740 |
CHILLS |
1 |
0.0000 |
| 741 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 742 |
DEHYDRATION |
1 |
0.0000 |
| 743 |
VISION BLURRED |
1 |
0.0000 |
| 744 |
COUGH |
2 |
0.0000 |
| 745 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 746 |
DRUG INTERACTION |
1 |
0.0000 |
| 747 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 748 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 749 |
COVID-19 |
1 |
0.0000 |
| 750 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 751 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 752 |
INJECTION SITE PAIN |
1 |
0.0000 |